These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38640809)

  • 1. Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases.
    van Schaik JE; van der Vegt B; Slagter-Menkema L; Hanemaaijer SH; Halmos GB; Witjes MJH; van der Laan BFAM; Fehrmann RSN; Oosting SF; Plaat BEC
    Am J Otolaryngol; 2024; 45(4):104298. PubMed ID: 38640809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein Nonmetastatic Melanoma Protein B as Potential Imaging Marker in Posttherapeutic Metastatic Head and Neck Cancer.
    van Schaik JE; Hanemaaijer SH; Halmos GB; Witjes MJH; van der Laan BFAM; van der Vegt B; Plaat BEC
    Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1202-1208. PubMed ID: 32600105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific growth rates calculated from CTs in patients with head and neck squamous cell carcinoma: a retrospective study performed in Austria.
    Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
    BMJ Open; 2019 Feb; 9(2):e025359. PubMed ID: 30782931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.
    Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ
    Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
    Do NY; Lim SC; Im TS
    Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
    Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors.
    O-charoenrat P; Rhys-Evans PH; Archer DJ; Eccles SA
    Oral Oncol; 2002 Jan; 38(1):73-80. PubMed ID: 11755824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Troy JD; Weissfeld JL; Youk AO; Thomas S; Wang L; Grandis JR
    Head Neck Pathol; 2013 Dec; 7(4):344-55. PubMed ID: 23645351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of new head and neck squamous cell carcinoma molecular imaging targets.
    van Schaik JE; van der Vegt B; Slagter-Menkema L; van der Laan BFAM; Witjes MJH; Oosting SF; Fehrmann RSN; Plaat BEC
    Oral Oncol; 2024 Apr; 151():106736. PubMed ID: 38422829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation.
    de Sousa EA; Lourenço SV; de Moraes FP; Vartanian JG; Gonçalves-Filho J; Kowalski LP; Soares FA; Coutinho-Camillo CM
    Head Neck; 2015 Oct; 37(10):1410-6. PubMed ID: 24824527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between [
    Surov A; Meyer HJ; Höhn AK; Winter K; Sabri O; Purz S
    Mol Imaging Biol; 2019 Apr; 21(2):368-374. PubMed ID: 29931433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of MRI Combined with CXCR4 Expression Level in Lymph Node Metastasis Head and Neck Squamous Cell Carcinoma.
    Zhao J; Li X; Wang M; Liu F; Wang J
    Comput Math Methods Med; 2022; 2022():4073918. PubMed ID: 35309836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma-Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis.
    Kawasaki Y; Suzuki H; Suzuki S; Yamada T; Suzuki M; Ito A; Hatakeyama H; Miura M; Omori Y
    Pathol Oncol Res; 2022; 28():1610450. PubMed ID: 36061142
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
    Seethala RR; Gooding WE; Handler PN; Collins B; Zhang Q; Siegfried JM; Grandis JR
    Clin Cancer Res; 2008 Mar; 14(5):1303-9. PubMed ID: 18316548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADC-histogram analysis in head and neck squamous cell carcinoma. Associations with different histopathological features including expression of EGFR, VEGF, HIF-1α, Her 2 and p53. A preliminary study.
    Meyer HJ; Leifels L; Hamerla G; Höhn AK; Surov A
    Magn Reson Imaging; 2018 Dec; 54():214-217. PubMed ID: 30189236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma.
    Wang B; Li M; Su A; Gao Y; Shi Y; Li C; Liu W; Su L; Li W; Ma Y
    Anal Cell Pathol (Amst); 2022; 2022():9303081. PubMed ID: 36090016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.
    Laban S; Giebel G; Klümper N; Schröck A; Doescher J; Spagnoli G; Thierauf J; Theodoraki MN; Remark R; Gnjatic S; Krupar R; Sikora AG; Litjens G; Grabe N; Kristiansen G; Bootz F; Schuler PJ; Brunner C; Brägelmann J; Hoffmann TK; Perner S
    Oncotarget; 2017 Feb; 8(9):14719-14735. PubMed ID: 28146422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma.
    van de Schootbrugge C; Bussink J; Span PN; Sweep FC; Grénman R; Stegeman H; Pruijn GJ; Kaanders JH; Boelens WC
    BMC Cancer; 2013 Mar; 13():128. PubMed ID: 23506259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.
    O-charoenrat P; Rhys-Evans P; Eccles SA
    Cancer; 2001 Aug; 92(3):556-68. PubMed ID: 11505400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
    Xu J; Müller S; Nannapaneni S; Pan L; Wang Y; Peng X; Wang D; Tighiouart M; Chen Z; Saba NF; Beitler JJ; Shin DM; Chen ZG
    Eur J Cancer; 2012 Jul; 48(11):1682-91. PubMed ID: 22341992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.